Onconova Therapeutics Inc. (ONTX) Sets New 52-Week Low at $3.13
Onconova Therapeutics Inc. (NASDAQ:ONTX) hit a new 52-week low on Thursday . The company traded as low as $3.13 and last traded at $3.36, with a volume of 64,317 shares traded. The stock had previously closed at $3.27.
Separately, Maxim Group initiated coverage on Onconova Therapeutics in a research note on Thursday. They set a “buy” rating and a $6.00 price objective for the company. One research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $24.74.
The company’s 50 day moving average price is $4.40 and its 200-day moving average price is $4.85. The firm’s market capitalization is $9.89 million.
Onconova Therapeutics (NASDAQ:ONTX) last posted its earnings results on Thursday, May 12th. The biopharmaceutical company reported ($0.27) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.19) by $0.08. On average, equities analysts predict that Onconova Therapeutics Inc. will post ($7.40) EPS for the current year.
Onconova Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways important to cancer cells. It has three clinical-stage product candidates and many preclinical programs that target kinases, cellular metabolism or cell division.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.